SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community discussion surrounding the company's shift toward post-TDAPA commercialization and expectations for upcoming earnings reports, with retail investors expressing frustration over recent price volatility and lack of communication from leadership. Meanwhile, the stock's institutional interest remains a focal point, as investors debate the potential long-term impact of the Melinta Therapeutics acquisition and the pending progress of the Kidney Care Access Protection Act.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is facing downward pressure following reports of hardware wallet security vulnerabilities and news that MicroStrategy has authorized a potential multi-billion dollar sale of its holdings. The community remains deeply divided, with some investors bracing for a deeper correction toward support levels in the 50s, while others view the pullback as a strategic accumulation opportunity ahead of anticipated legislative developments.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is currently trending as investors debate its role as a sovereign cloud infrastructure project versus its historical price performance. The community is actively discussing recent ecosystem developments, such as the MCP Server Beta and Cloud Engines, while weighing these long-term technical milestones against the bearish sentiment surrounding the broader crypto market.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is trending as energy markets digest news of the Iran peace deal, with investors weighing the potential for increased oil flows against persistent geopolitical risks and critical infrastructure damage. While community sentiment remains split, active discussions center on whether the recent pullback offers a buying opportunity in a structurally undersupplied market, or if the sector faces further downside as diplomatic efforts attempt to normalize energy transport through the Strait of Hormuz.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed retail interest and speculation as investors trade volatility around recent price action and burning activity. The community is actively debating whether current momentum marks a sustainable breakout or a temporary squeeze in a broader meme coin market cycle.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is experiencing heightened trader attention as Bitcoin faces significant sell pressure and breaks below key support levels, prompting a surge in bearish put-side hedging among market participants. Investors are currently weighing the impact of broader institutional outflows and ongoing volatility, with community debate centered on whether these price levels represent a generational buying opportunity or the continuation of a deeper cyclical downturn.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently in the spotlight as investors rotate into defensive, high-quality healthcare names amid broader market volatility and uncertainty in high-growth tech sectors. The community is actively monitoring upcoming clinical trial data and strategic pipeline expansions in oncology, with ongoing discussions centered on JNJ's ability to navigate litigation headwinds while maintaining its status as a reliable blue-chip dividend stock.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining traction due to anticipation surrounding its upcoming multi-chain merger and expanded integration into the Ethereum ecosystem. Community sentiment remains focused on institutional accumulation and the protocol's dominance as a primary liquidity hub on the Base network, with many investors viewing current price action as a key accumulation opportunity ahead of these long-term catalysts.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors grapple with its prolonged technical weakness, characterized by an extended period below the 200-day moving average, while debating whether to treat the metal as a safe-haven hedge against rising national debt and geopolitical instability or as a vulnerable asset prone to liquidation during market volatility. Community discourse remains deeply divided between long-term bulls accumulating positions due to systemic debt concerns and central bank buying, and skeptics who highlight recent outflows and the asset's failure to decouple from broader equity market trends.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is trending as investors digest news of a massive data center financing deal involving Meta, while the asset manager simultaneously benefits from a record-breaking expansion in assets under management. Market participants are actively discussing the firm's pivotal role in AI-related infrastructure and its continued dominance in institutional flows and ETF growth.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings; other stocks declining in pre-market tradingread more...

Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection

Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection...

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs 

Alvotech shares surge after the company resubmits FDA applications for its biosimilar candidates, AVT05 and AVT06, with reviews expected within six months.

Alvotech (ALVO) Q4 2025 Earnings Transcript

Alvotech (ALVO) Q4 2025 Earnings Transcript...

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) delivered earnings and revenue surprises of -28.57% and -22.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Alvotech (NASDAQ:ALVO) Announces Earnings Results

Alvotech (NASDAQ:ALVO - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $999.07. Alvotech had a negative return on equity of 11.92% and a net margin of...

Alvotech (NASDAQ:ALVO) Trading 7.1% Higher - Still a Buy?

Alvotech (NASDAQ:ALVO) Trading Up 7.1% - Here's Why...

Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Alvotech (NASDAQ:ALVO - Get Free Report) have earned an average recommendation of "Hold" from the six ratings firms that are presently covering the company, Marketbeat reports. Two...

Wall Street Zen Upgrades Alvotech (NASDAQ:ALVO) to Hold

Wall Street Zen raised shares of Alvotech from a "sell" rating to a "hold" rating in a research note on Saturday...

Alvotech (NASDAQ:ALVO) Sees Significant Increase in Short Interest

Alvotech (NASDAQ:ALVO - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totaling 3,000,511 shares, a growth of 22.1% from the March 15th total of 2,457,228 shares. Currently, 1.0% of the shares of the stock are short sold...

$ALVO Q1 '26 Earnings Results & Recap

Management anticipates Alvotech's total revenues to be in the range of $650M and adjusted EBITDA in the range of $180M in 2026, with the lower revenue end assuming no new U.S. market launches.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Why Is ALVO Stock Rising Pre-Market Today?

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALVOAlvotech

Fundamentals

Connect Stocktwits to ChatGPT

Latest ALVO News